Last reviewed · How we verify

E-Z-Hd — Competitive Intelligence Brief

E-Z-Hd (BARIUM SULFATE) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Radiographic Contrast Agent [EPC]. Area: Gastroenterology.

marketed Radiographic Contrast Agent [EPC] Gastroenterology Small molecule Live · refreshed every 30 min

Target snapshot

E-Z-Hd (BARIUM SULFATE).

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
E-Z-Hd TARGET BARIUM SULFATE marketed Radiographic Contrast Agent [EPC] 2016-01-01
Imeron IOMEPROL marketed Radiographic Contrast Agent [EPC] 2024-01-01
Visipaque 270 IODIXANOL GE HealthCare marketed Radiographic Contrast Agent 1996-01-01
Ioxitol IOXILAN Guerbet marketed Radiographic Contrast Agent 1995-01-01
Ultravist 370 IOPROMIDE Bayer marketed Radiographic Contrast Agent 1995-01-01
Optiray 320 IOVERSOL Liebel-Flarsheim marketed Radiographic Contrast Agent [EPC] 1988-01-01
IOPAMIDOL IOPAMIDOL marketed Radiographic Contrast Agent [EPC] 1985-01-01

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Radiographic Contrast Agent [EPC] class)

  1. · 5 drugs in this class
  2. Deseret Biologicals, Inc. · 1 drug in this class
  3. GE HealthCare · 1 drug in this class
  4. Liebel-Flarsheim · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). E-Z-Hd — Competitive Intelligence Brief. https://druglandscape.com/ci/barium-sulfate. Accessed 2026-05-13.

Build your own brief

Pick any drug + add comparators: